Inanc, N. Et Al. 2023. Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib. Journal of Clinical Rheumatology , vol.29, no.8 , 365-369.

Inanc, N., Abacar, K. Y., Ozturk, M. A., Tufan, A., Karadeniz, H., Sari, I., ... Can, G.(2023). Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib. Journal of Clinical Rheumatology , vol.29, no.8, 365-369.

Inanc, Nevsun Et Al. "Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib," Journal of Clinical Rheumatology , vol.29, no.8, 365-369, 2023

Inanc, Nevsun Et Al. "Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib." Journal of Clinical Rheumatology , vol.29, no.8, pp.365-369, 2023

Inanc, N. Et Al. (2023) . "Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib." Journal of Clinical Rheumatology , vol.29, no.8, pp.365-369.

@article{article, author={Nevsun Inanc Et Al. }, title={Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib}, journal={Journal of Clinical Rheumatology}, year=2023, pages={365-369} }